Robert Wayne Yeh MD MSc, MBA

Interventional Cardiology

Section Chief of Interventional Cardiology, Beth Israel Deaconess Medical Center. Katz-Silver Family Professor of Medicine in the Field of Cardiovascular Outcomes Research, Harvard Medical School. Director, Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center.

Join to view full profile

375 Longwood Ave, 4th FloorBeth Israel Deaconess Medical Center, Baker 4Boston, MA 02215
Phone+1 617-632-7701

Dr. Yeh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yeh's full profile Already have an account?

Summary

Dr. Robert Yeh is an interventional cardiologist based in Boston, MA, specializing in complex coronary intervention. He received his medical education at Harvard Medical School and completed fellowships in cardiovascular disease and interventional cardiology at the University of California (San Francisco) and Massachusetts General Hospital. Dr. Yeh holds an MBA from the University of Oxford and a Master's in Health Policy from the London School of Hygiene and Tropical Medicine and LSE. He is the Section Chief of Interventional Cardiology and Director of the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center. His expertise includes myocardial infarction and angioplasty, and he is extensively published on topics related to cardiology. Dr. Yeh has led several clinical trials and has been recognized with honors such as the Joseph A. Vita Award from the American Heart Association and membership in the American Society for Clinical Investigation.

Education & Training

Harvard Medical SchoolClass of 2003
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine
Mass General Brigham/Massachusetts General HospitalFellowship, Interventional Cardiology
University of California (San Francisco)Fellowship, Cardiovascular Disease
University of OxfordMBA, Business Administration, Distinction

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2006 - Present
MA State Medical License 2005 - 2027
WA State Medical License 2015 - 2015
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Member American Society for Clinical Investigation, 2024
Joseph A. Vita Award American Heart Association, 2020
Fellow (FACC) American College of Cardiology

Clinical Trials

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study) Start of enrollment: 2020 Jul 01
COMPLETED
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) Start of enrollment: 2021 May 11
ACTIVE_NOT_RECRUITING
PHASE3
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment Start of enrollment: 2023 Jun 21
ACTIVE_NOT_RECRUITING
NA

Publications & Presentations

PubMed

DOAC score among patients receiving Vitamin K antagonists.
Rahul Aggarwal, Christian T Ruff, Michael G Palazzolo, Fionn Cléirigh Büttner, Karen Pieper
American Heart Journal. 2026-11-01
Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval Study.
Christina Lalani, Eric A Secemsky, Yang Song, Huaying Dong, Ajay J Kirtane
Circulation. Cardiovascular Interventions. 2026-08-01
Long-term Cardiovascular Outcomes in US Medicare Beneficiaries After COVID-19 Hospitalization During the Omicron Era.
Sérgio R R Decker, Yang Song, Issa J Dahabreh, Robert W Yeh, Dhruv S Kazi
Circulation. Population Health and Outcomes. 2026-08-01

Journal Articles

Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction with Multivessel Coronary Artery Disea...
Eric A Secemsky, Jeptha P Curtis, Salim S Virani, Ehrin J Armstrong, Kendrick A Shunk, Deepak Bhatt, Robert W Yeh, JAMA Cardiology
Misclassification of Hospital Performance Under the Hospital Readmissions Reduction Program
Rishi K Wadhera, Robert W Yeh, JAMA Cardiology
Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in t...
Rohan Khera, Eric A Secemsky, Harlan M Krumholz, Kendrick A Shunk, Salim S Virani, Deepak L Bhatt, Jeptha Curtis, Robert W Yeh, JAMA Internal Medicine

Lectures

Mini-Focus Issue: Payer Issues and Patient Access Clinical Research 30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019

Authored Content

Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018August 2020
Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionMay 2020

Press Mentions

Breaking Through a Hidden Heart BlockageApril 14th, 2026
Cardio Procedures Are Moving Out of Hospitals. Is That Good?August 21st, 2025
Shockwave Initiates FORWARD CAD IDE Study of Javelin Coronary IVL CatheterApril 7th, 2025

Grant Support

Training program in Resuscitation ScienceBETH ISRAEL DEACONESS MEDICAL CENTER2021–2031
Mentoring and Research in Cardiovascular Device EvaluationBETH ISRAEL DEACONESS MEDICAL CENTER2020–2030
Mentoring and Research in Cardiovascular Device EvaluationBETH ISRAEL DEACONESS MEDICAL CENTER2020–2030
Mentoring and Research in Cardiovascular Device EvaluationBETH ISRAEL DEACONESS MEDICAL CENTER2020–2030
Application of Modern Methods to Predict Risk and Estimate Treatment Effectiveness in Cardiogenic ShockBETH ISRAEL DEACONESS MEDICAL CENTER2025–2029

Professional Memberships

American College of Cardiology - ACC
Fellow
Society for Cardiovascular Angiography and Interventions
Fellow
American Heart Association - AHA
Fellow

External Links

PCI for Chronic Total Occlusionhttp://www.bidmc.org/ctocare
Richard and Susan Smith Center for Outcomes Researchhttp://www.bidmc.org/smithcenter
Harvard Profilehttps://connects.catalyst.harvard.edu/Profiles/display/Person/30625